BSX
Boston Scientific Corporation
Stock
$42.60−0.63 (−1.46%)Close Oct 2, 2026
- Selling, general and administrative, 2025
- $6.9B
- YoY, 2025
- +15.1%
- 5-year CAGR
- +12.7%
- 10-year CAGR
- +9.1%
Selling, general and administrative
Selling, general and administrative by fiscal year
| Period | SG&A | YoY |
|---|---|---|
| 2025 | $6.9B | +15.1% |
| 2024 | $6.0B | +15.3% |
| 2023 | $5.2B | +14.8% |
| 2022 | $4.5B | +3.7% |
| 2021 | $4.4B | +15.1% |
| 2020 | $3.8B | −3.9% |
| 2019 | $3.9B | +10.4% |
| 2018 | $3.6B | +8.3% |
| 2017 | $3.3B | +6.3% |
| 2016 | $3.1B | +7.9% |
| 2015 | $2.9B | −1.0% |
| 2014 | $2.9B | +8.5% |
| 2013 | $2.7B | +5.5% |
| 2012 | $2.5B | +1.9% |
| 2011 | $2.5B | −3.6% |
| 2010 | $2.6B | −2.1% |
| 2009 | $2.6B | +1.8% |
| 2008 | $2.6B | −11.0% |
| 2007 | $2.9B | — |